This is consistent with the general paradigm seen in other sarcomas: Eisinger-Mathason et al. demonstrated that deletion of HIF-1α in sarcoma models did not impede primary tumor growth but significantly suppressed metastatic progression. The gene discussed is HIF1A; the disease is neoplasm.